Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample type	Gender
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	2515	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	2697	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	3075	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	176321	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	178277	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	179820	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	185667	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	191797	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	193733	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	196326	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	202813	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	204652	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	206146	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	206575	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	206710	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	208037	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	208291	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	210276	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	211552	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	212110	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	213236	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	214248	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	215940	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	217851	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	218239	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	219170	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	220071	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	220249	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	224214	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	226549	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	226979	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	228322	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	228668	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	229898	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	231869	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	232177	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	232289	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	232373	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	232878	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	234260	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	234566	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	235067	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	235132	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	235230	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	236473	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	238212	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	240679	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	242877	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	243647	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	244757	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	245822	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	246292	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	247971	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	251094	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	252203	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	252480	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	252588	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	252997	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	255912	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	255914	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	256553	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	256765	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	256971	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	265757	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	265895	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	267609	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	267693	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	271196	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	272590	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	272627	Peak area normalized	red cross plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	272744	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	273077	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	274008	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	274763	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	275056	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	276997	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	278152	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	278505	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	279595	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	279886	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	280152	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	280321	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	283348	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	283470	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	284658	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	284805	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	284837	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	285543	Peak area normalized	chear plasma	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	286060	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	286434	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	287524	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	290153	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	290399	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	292256	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	293167	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	293996	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	295356	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	295507	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	297801	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	298051	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	299602	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	299918	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	301050	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	301560	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	301636	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	302243	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	302927	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	303415	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	303437	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	303806	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	305037	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	306294	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	307501	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	307561	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	308124	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	308441	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	309058	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	309265	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	309750	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	311495	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	311547	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	311785	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	311909	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	311985	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	312103	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	312866	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	313186	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	316294	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	317969	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	319221	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	319803	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	320408	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	321787	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	322864	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	324444	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	325327	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	325476	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	325767	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	326899	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	327831	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	327891	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	328185	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	329105	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	329152	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	329952	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	330907	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	331055	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	331177	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	331539	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	331694	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	331966	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	332380	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	332817	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	332855	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	332857	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	333030	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	333224	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	333340	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	333824	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	334174	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	334206	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	334315	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	334670	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	334766	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	334993	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	335135	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	335421	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	335873	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	335931	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	336251	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	336313	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	336512	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	336677	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	336894	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	336952	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	337012	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	337576	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	338266	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	338316	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	338463	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	338527	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	339021	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	339113	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	339201	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	339358	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	340044	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	340084	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	340286	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	340309	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	340698	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	341282	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	341729	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	342885	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	343017	Peak area normalized	batch pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	344984	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	345503	Peak area normalized	master pool	-
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	346236	Peak area normalized	Sample	male
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	349574	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	350929	Peak area normalized	Sample	female
Reversed Phase POSITIVE (Named metabolites)	pyroglutamate	352165	Peak area normalized	Sample	male

Return to search page